Ardena在荷兰新建的纳米医疗设施得到全球监测方案的全面批准,促进了先进的药物生产。 Ardena's new nanomedicine facility in the Netherlands receives full GMP approval, boosting advanced drug production.
一家制药公司Ardena在荷兰奥斯的新纳米医疗设施获得全球监测方案的全面批准。 Ardena, a pharmaceutical company, has received full GMP approval for its new nanomedicine facility in Oss, Netherlands. 经荷兰保健局批准,2 000万欧元的45 000平方英尺设施包括符合GMP要求的清洁室、实验室和仓库,用于制造先进的纳米药物,包括纳米粒子和成像剂。 Approved by the Dutch Healthcare Authority, the €20 million, 45,000 sqft facility includes GMP-compliant cleanrooms, labs, and warehouses for manufacturing advanced nanomedicines, including nanoparticles and imaging agents. 这一里程碑支持Ardena将创新疗法投放市场的目标。 This milestone supports Ardena's goal of bringing innovative therapies to market.